- Home
- LVLU vs TXMD Comparison
LVLU vs TXMD Comparison
Compare LVLU & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVLU | TXMD |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4M | 21.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LVLU | TXMD |
|---|---|---|
| Price | $5.04 | $1.63 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 24.1K | ★ 65.6K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $285,413,000.00 | $2,796,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | $2.53 | N/A |
| P/E Ratio | ★ N/A | $269.20 |
| Revenue Growth | N/A | ★ 75.19 |
| 52 Week Low | $2.98 | $0.70 |
| 52 Week High | $18.00 | $2.44 |
Technical Indicators
Market Signals| Indicator | LVLU | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 53.21 |
| Support Level | $5.00 | $1.62 |
| Resistance Level | $5.13 | $2.01 |
| Average True Range (ATR) | 0.42 | 0.16 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 25.17 | 44.83 |
Price Performance
Historical ComparisonAbout LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.